(Total Views: 1008)
Posted On: 05/08/2020 8:54:16 AM
Post# of 155685
The Playbook - Lawsuits and Class Action
https://medicalnewsfirst.com/anatomy-of-cytod...ess-lives/
They will come out with an article that talks about the patients and how some of them have been paid to give testimony. In fact, years ago about 7 patients on leronlimab for HIV treatment did video testimonies about how great PRO 140 (leronlimab) was in treating their HIV. The shorts attacked this as paid advertising. If you follow their playbook, the next thing will be class action lawsuits or a focus on the existing lawsuit filed April 24th, between the Ex Chairman of CytoDyn Anthony Caracciolo who used to was an SVP at GILD, yet couldn’t get a licensing deal done for shareholders during his tenure. Wait… shorts already played that card on Friday when they announced “CytoDyn Executives Sued for ‘Oversized’ Stock Awards.’”
Written 4 Days ago - how prohetic
https://medicalnewsfirst.com/anatomy-of-cytod...ess-lives/
They will come out with an article that talks about the patients and how some of them have been paid to give testimony. In fact, years ago about 7 patients on leronlimab for HIV treatment did video testimonies about how great PRO 140 (leronlimab) was in treating their HIV. The shorts attacked this as paid advertising. If you follow their playbook, the next thing will be class action lawsuits or a focus on the existing lawsuit filed April 24th, between the Ex Chairman of CytoDyn Anthony Caracciolo who used to was an SVP at GILD, yet couldn’t get a licensing deal done for shareholders during his tenure. Wait… shorts already played that card on Friday when they announced “CytoDyn Executives Sued for ‘Oversized’ Stock Awards.’”
Written 4 Days ago - how prohetic
(1)
(0)
